MENDES SRL has a total of 45 patent applications. Its first patent ever was published in 1993. It filed its patents most often in WIPO (World Intellectual Property Organization), Italy and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are DYNAMIS THERAPEUTICS INC, VIROCELL INC and MEDVILL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | Italy | 8 | |
#3 | Canada | 5 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Republic of Korea | 3 | |
#6 | United States | 3 | |
#7 | South Africa | 3 | |
#8 | Australia | 2 | |
#9 | Brazil | 2 | |
#10 | China | 1 | |
#11 | Algeria | 1 | |
#12 | Israel | 1 | |
#13 | India | 1 | |
#14 | Japan | 1 | |
#15 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Organic fine chemistry | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Microorganisms | |
#5 | Foods | |
#6 | Bakery products | |
#7 | Edible oils | |
#8 | Specific use of cosmetics | |
#9 | Unspecified technologies | |
#10 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | De Simone Claudio | 23 |
#2 | Moretti Sonia | 10 |
#3 | Simone Claudio De | 5 |
#4 | Contini Carlo | 3 |
#5 | Tzoutzoglou Sonia | 3 |
#6 | Bruschi Pietro | 3 |
#7 | Kim Seok-Jin | 2 |
#8 | Ladelwat Philip | 1 |
#9 | Desimone Claudio | 1 |
#10 | Simone C De | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020261055A1 | Composition with antibacterial and re-epithelializing action including probiotics | |
AU721430B1 | Symbiotic functional food | |
KR20010106092A | Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria | |
EP0909171A1 | Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 | |
TW513304B | Use of an alkanoyl L-carnitine or a pharmacologically acceptable salt thereof for the therapeutic treatment or prophylaxis of glutamate-mediated disturbances or diseases | |
WO9712598A2 | Dermatological and cosmetic compositions suitable for topical application, having modulating effect on the endogenous ceramide of the skin | |
WO9628186A1 | Use of g class immunoglobulins for the topical treatment of atopic dermatitis | |
CA2157590A1 | Use of terbinafine for the therapeutic treatment of pneumocystosis |